SAFIRA is the Latest Addition to our Pain Management Product Range
With a revolutionary new technology that makes regional anaesthesia a one-person procedure, putting control in the hands of the anaesthetist. It allows a single operator, an anaesthetist, to conduct the whole regional block at safer pressures.
Reduces the Risk of Nerve Damage and Improves Patient Outcomes
Anaesthetic solutions are often injected at high pressure, which can cause nerve damage. Serious nerve damage occurs in up to 1% of procedures and transient nerve damage in up to 8% of cases.
SAFIRA helps to prevent injection at unsafe pressures. The built-in safety system limits injection pressure to less than 20psi by automatically stopping, reducing the risk of nerve damage during Regional Anaesthesia. Helping to promote better outcomes for both professionals and patients.
WINNER: “Patient Safety Innovation of the Year” at the HSJ Patient Safety Awards 2021
Saves Time & Reduces Costs
SAFIRA saves five minutes per procedure and limits the costs associated with extra operators* When time is money, SAFIRA saves you both.
*Reference: Fong-Soe-Khioe R. Health Economic report Medovate commissioned written by a health economist from the University of East Anglia (UEA). Disclaimer: *Example time saving – Time savings will be dependent on organisational and procedural circumstances.
VYGON is the appointed distributor for Europe and the UK.
Interested in trialling SAFIRA?
Revolutionise regional anaesthesia procedures in your department
Get in touch with your Vygon representative today to discuss your current pain management procedures and how SAFIRA can be used to promote better outcomes.
